Prokidney Corp. shares closed at $0.96 on Monday, 2 November, their lowest close in a year and 25.9% below the previous 52-week low of $1.29 set on 30 October 2026. The shares have fallen 68.8% over the past year, excluding dividends.
What stands out
Growth has slowed: revenue over twelve months rose 55.2%, 135.3 percentage points less than the rate a quarter earlier.
The share price
Over the previous 52 weeks the shares closed between $1.29 and $3.08. Over longer periods the shares are down 47.7% over three years and down 90.3% over five years, excluding dividends.
Growth
The business is getting more profitable as it grows. Revenue over the twelve months to Q2 2026 was $818,000, which rose 55.2% on the year before. That growth rate was down 135.3 percentage points on the rate a quarter earlier.
Margins and profit
The company is still loss-making. The trailing operating margin was negative, at −21664.5%, up 12802.4 percentage points from a year earlier. The trailing net margin was negative, at −10288.4%. The company made a net loss of $84.2 million over the twelve months.
Where the cash went
Operating cash flow over the twelve months was −$141.2 million. Capital spending was $18.6 million, or 2269.8% of revenue. At the same time, free cash flow, operating cash flow less capital spending, was −$159.7 million. Free cash flow was −19527.4% of revenue (the free-cash-flow margin), up 8286.7 percentage points from a year earlier.
What comes next
A 52-week low says where the market's price has gone, not why: the next results will show whether the trends in the filings above support it.